China steps up decentralized drug industry regulation, market prices push
China authorities at the highest level are acting on legislation that would, among other things, decentralize drug industry regulation and free some price controls. The State Council, China's cabinet, is meeting this week to consider bills and amendments intended to give some regulatory relief to several industries, including pharmaceutical. Read more | Subscribe to FiercePharmaAsia
China authorities at the highest level are acting on legislation that would, among other things, decentralize drug industry regulation and free some price controls. The State Council, China's cabinet, is meeting this week to consider bills and amendments intended to give some regulatory relief to several industries, including pharmaceutical. Read more | Subscribe to FiercePharmaAsia
No comments:
Post a Comment